Plavix Rebates Aim To Stem Market Share Losses After Generic Launch

Sanofi-Aventis and Bristol-Myers Squibb have initiated a program offering "large" rebates to third-party payers for Plavix to counter generic competition from Apotex, the companies said

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet